References
- Smith K A, Lachman L B, Oppenheim J J, Favata M F. The functional relationship of the interleukins. J Exp Med 1980; 151: 1551–1560
- Kaye K S, Gillis S, Misel S B, Shevach E M, Malek T R, Dinarello C A, Lachman L B, Janeway C A. Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: Interleukin–1 is required for the expression of receptors for Interleukin–2. J Immunol 1984; 133: 1339–1344
- Kurt-Jones E A, Hamberg S, Ohara J, Paul W E, Abbas A K. Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J Exp Med 1987; 166: 1774–1784
- Weaver C T, Hawrylowicz C M, Unanue E R. T helper T cell subsets require the expression of distinct costimulatory signals by antigen–presenting cells. Proc Natl Acad Sci USA 1988; 85: 8181–8186
- Dinarello C A. Interleukin 1 and the pathogenesis of acute phase response. N Engl J Med 1984; 311: 1413–1421
- Theofilopoulos A N, Dixon F J. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269–288
- Donnelly R P, Levine J, Hartwell D W, Frendl G, Fenton M J, Beller D I. Aberrant regulation of IL–1 expression in macrophages from young autoimmune–prone mice. J Immunol 1990; 145: 3231–3339
- Jacob C O, Aiso S, Michi S A, McDevitt H O, Acho–Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF–α and interleukin 1. Proc Natl Acad Sci USA 1990; 87: 968–972
- Satoh J, Seino H, Tanaka S-I, Shintani S, Otha S, Tamura K, Sawai T, Nubunaga T, Oteki T, Kumagai K. Toyota T.2 Recombinant human tumor necrosis factor suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989; 84: 1345–1348
- Sandler S, Bendtsen K, Eisirik D L, Strandall E, Welsh M, Welsh N. Metabolism and beta–cell function of rat pancreatic islets exposed to human interleukin–1 beta in the presence of high glucose concentration. Immunology Letters 1990; 26: 245–251
- Comens P G, Wolf B A, Enanue E R, Lacy P E, McDaniel M L. Interleukin 1 is a potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes 1987; 36: 963–970
- Wilson C A, Jacobs C, Baker P, Baskin D G, Dower S, Lernmark A, Toivola B, Vertrees S, Wilson D. IL–1 beta modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J Immunol 1990; 144: 3784–3788
- Del Rey A, Besedovsky H. Interleukin affects glucose homeostasis. Am J Physiol 1987; 253: R794–R798
- Haskins K, McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet specific T cell clone. Science 1990; 249: 1433–1436
- Thivolet C, Bendelac A, Bedossa P, Bach J-F, Carnaud C. CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+T cell–dependent. J Immunol 1991; 146: 85–88
- Wicker L S, Miller B J, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from diabetic non obese diabetic mice. Diabetes 1985; 35: 855–861
- Miller B J, Appel M C, O'Neil J J. Wicker LS. Both lyt–2+ and L3T4+ T cell subsets are required for the transfer of diabetes in non obese diabetic mice. J Immunol 1988; 140: 52–57
- Del Rey A, Besedovsky H. Antidiabetic effects of Interleukin 1. Proc Natl Acad Sci USA 1989; 86: 5943–5947
- Formby B, Miller N. Autologous CD4 T–cell responses to ectopic class II major histocompatibility complex antigen–expressing single–cell islet cells: An in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice. Proc Natl Acad Sci USA 1990; 87: 2438–2442
- Nakado N, Kikutani H, Nishimoto H, Kishimoto T. T cell receptor V gene usage of islet beta cell–reactive T cells is not restricted in non–obese diabetic mice. J Exp Med 1991; 173: 1091–1097
- Hughes J H, Colca J R, Easom R A, Turk J, McDaniel M L. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 1990; 86: 856–863
- Serreze D V, Leiter E H. Defective activation of suppressor T cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. J Immunol 1988; 140: 3801–3807
- Hafler D A, Chofflon M, Kurt-Jones E, Weiner H I. Interleukin–1 corrects the defective autologous mixed lymphocyte response in Multiple Sclerosis. Clin Immunol lmmunopathol 1991; 58: 115–125